Besonders bemerkenswerte Abschnitt habe ich farblich und fett hervorgehoben.
Eine deutsche Übersetzung
finden Sie hier.
April 05, 2001
In 2000, the President of South Africa
invited a number of scientists of different backgrounds and different views to serve on a panel to discuss
HIV/Aids. The panel met on two occasions in May and July in South Africa and exchanged views in an Internet
discussion during the two months in between. A total of 52 scientists participated in these discussions.
The
main questions raised were:
-
What causes the immune deficiency that
leads to death from AIDS?
-
What is the most efficacious response
to this cause or causes?
-
Why is HIV/AIDS in sub-Saharan Africa
heterosexually transmitted while in the western world it is said to be largely homosexually transmitted?
-
What is the role of therapeutic
interventions in the context of developing countries?
-
The discussions above should be
underpinned by considerations of the social and economic context, especially poverty and other prevalent
co-existing diseases and the infrastructural realities of developing countries.
The
report released on 4 April 2001 summed up the interventions and discussions that took place.
The most striking aspect during all
discussions was a division into two groups:
·
Those scientists who put forward
arguments in favour of HIV as being necessary and sufficient to cause Aids. Aids, in turn, leads necessarily to
death and therefore has to be treated with antiretroviral drugs.
·
Those scientists who put forward
arguments for HIV not being the cause of Aids, for Aids being an artificial list of old, well known and treatable
diseases and anti-retrovirals as being toxic and in part responsible for people suffering and dying from what is
called Aids.
It was
the first time in the history of HIV/Aids that scientists from different views were invited with the intention of
finding common ground.
The individual interventions and arguments
will not be repeated in this summary as they have been published already. Instead, the recommendations and
conclusions will be cited together with a short analysis.
Arguments and views were totally divided and no common conclusion could be reached.
A surprising “General recommendation” is given at the end of this
chapter: “There was general consensus on the need for the case definition of AIDS to be standardised for
clinical practice in South Africa.” This recommendation was necessary because no clinical guideline for the
diagnosis of Aids in South Africa was presented to the panel. Only the Health Ministry’s
reporting form for Aids cases was available. Aids is defined in
this form on the basis of unspecific criteria like fever, diarrhoea and weight loss. An HIV-test is only optional.
(This definition is based on the so-called Bangui-definition of WHO.)
Another surprising aspect was the lack of data. Or as the report puts it:
“The deliberations of
the panel were at all times bedevilled by the absence of accurate and reliable data and statistics on the
magnitude of the AIDS problem or even HIV prevalence in South Africa. Repeated requests for such data and
statistics, particularly by panellists who refuted the causal link between HIV and AIDS, failed to result in the
provision of such data by either South African panellists or the officials of the Department of Health.”
Therefore the following general recommendation was given: “to collect the data and
develop reliable and up-to-date statistics on the magnitude of AIDS and prevalence of HIV in South Africa”.
A good example of the underlying problem is given in the report itself. At the end of the last meeting, Dr.
Makgoba presented statistics on mortality in SA from 1990 to 1999. These data showed a steady and linear increase
of mortality, especially in the age-group 20-60 years. A parallel increase of HIV-positive results in the
antenatal screening was observed during the same period. Dr. Makgoba presented these data as proof of an
Aids-epidemic – but his interpretation ignores the widely believed concept of an average incubation period of 8-10
years. If anything, these data would indicate that HIV cannot be made responsible for an increased mortality
during that period. Unfortunately there was no discussion on these data as they were not made available to the
other members of the panel and were presented only at the end of the last meeting.
Dr Makgoba’s interpretation on this very basic subject is further complicated by comments from Statistics South
Africa, which said: “ Stats SA has several problems with
this interpretation”. It concluded on the age-specific mortality that “the 1999 profile is not a drastically new
profile as portrayed.”
However, Statistics South Africa is well aware of the real problems in the country: “the largest proportion of
causes of death among males was unnatural causes. The breakdown shows that 27% of South African males die of
accidents and violent deaths.”
Statistics South Africa argued that the data from 1990 cannot be compared with 1999, as dramatic changes had taken
place during that period. (i.e. Former Homelands were included in the statistics only after 1994 and the age
distribution of the population had changed over time being demographically younger now.)
The report writes: “The key issue that came under focus was the
reliability of the ELISA testing. ... A major recommendation arising from the two meetings was to apply a series
of HIV tests of increasing stringency in order to establish the validity, veracity, rigour, reliability and
concordance of ELISA, PCR and viral isolation.”
It seems surprising to start studies on the reliability on HIV-test when they have been used for more than 15
years. Therefore it is safe to conclude that the decision to conduct studies to investigate the reliability was
made because they had not yet been done.
(All predictions on HIV and Aids in South Africa are based on a sentinel screening in public antenatal clinics.
One single ELISA test is used in this screening to diagnose HIV-infection.)
The views were strongly divided on the need and danger of so-called anti-retroviral drugs.
Nevertheless the report concludes: “The toxicity of anti-retroviral
drugs was not in dispute from any of the panellists.”
Any recommendation on this subject is based on the understanding of the aetiology and the understanding of the
nature of HIV and Aids. The views and arguments on both sides were diametrically opposed. No general conclusion
could be reached on this subject.
The panel was invited to discuss possible
reasons and the magnitude of the HIV/Aids epidemic in South Africa – and to make recommendations on how to combat
it.
General agreement was reached however on
the following major problems:
-
Lack of reliable data
Neither the SA health authorities nor the South African panel members presented data which indicated an increased
mortality, not to mention an Aids epidemic.
-
Lack of data concerning the
reliability of HIV-testing
It was decided to undertake studies to assess the reliability of the HIV-tests, especially the ELISA test, because
it is the most frequently used test in SA. (All predictions on HIV and Aids in South Africa are based on a
sentinel screening in public antenatal clinics. One single ELISA test is used in this screening to diagnose
HIV-infection.)
-
Lack of a reliable definition for
Aids
Three symptoms out of a list of unspecific clinical symptoms are used in the Ministry of Health’s reporting form
for Aids. (I.e. Fever, diarrhoea, weight loss, general itching, coughing etc. An HIV-test is optional in the
diagnosis of Aids. This definition is known as the Bangui definition and was accepted by WHO in 1985.) No other
document was presented to the panel showing the definition of Aids used by doctors in South Africa. The following
recommendation was therefore approved: “There was general consensus on the need for the case definition of AIDS to
be standardised for clinical practice in South Africa.”
Therefore any recommendation concerning treatment or prevention has to be discussed on the basis of a complete
lack of basic data. The panel was not provided with any reliable data whether there is a problem at all and if
so of what magnitude. This is especially worrisome when it comes to the use of so-called antiretroviral
drugs. It should be recalled that the report writes: “The toxicity
of anti-retroviral drugs was not in dispute from any of the panellists.”
The
following questions arise after reading the report:
Why is it that we ask these very basic questions only after almost 20 years of Aids-hysteria? And what did we do
during this time when we fought against “HIV/Aids”?
|
Christian Fiala |
MD, Department of Obstetrics and Gynaecology, General Public Hospital Korneuburg, Austria |
<christian.fiala@aon.at> |
|
Ettiene de Harven |
Prof. emerit (Pathology) Univ. of Toronto, Canada |
<pitou.deharven@wanadoo.fr> |
|
Peter Duesberg |
Prof., Dept. Mol. & Cell Biol. Stanley Hall UC Berkeley |
<duesberg@uclink4.berkeley.edu> |
|
Claus Koehnlein |
MD, Specialist in Interne Medicine, Kiel, Germany |
<Koehnlein-Kiel@t-online.de> |
|
Heinz Spranger |
Univ.-Prof.a.D.Dr.Dr.h.c., German Association of medical and non-medical health Practitioners (Aktions-Kreis Heilberufe in Deutschland). |
<IPOM.Spranger@t-online.de> |
All are invited members of the South African Presidential Aids Advisory Panel
Hier finden Sie die oben erwähnten afrikanischen Meldeformulare für AIDS-Fälle.